Swiss National Bank

Bank

Position in URGN — UroGen Pharma Ltd.

CIK 1582202 ZURICH, V8

Position in URGN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$2,863,040

+$1,464,196 QoQ

Shares Held

77,800

0.0% QoQ

Ownership

0.159%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#53

of 190 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. URGN ranks #92 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	717,440	$356,373,971
2	REGN	Regeneron Pharmaceuticals, Inc.	293,020	$182,709,690
3	ALNY	Alnylam Pharmaceuticals, Inc.	374,080	$112,609,302
4	RVMD	Revolution Medicines, Inc.	456,331	$85,461,669
5	RPRX	Royalty Pharma plc	1,159,800	$65,029,986
6	INSM	INSMED Inc	593,512	$63,280,249
7	INCY	Incyte Corp	476,874	$54,058,436
8	MRNA	Moderna, Inc.	679,900	$47,613,397

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,863,040	77,800	0.0%	Shares	Sole	2026-08-11
2026-03-31	$1,398,844	77,800	+37.5%	Shares	Sole	2026-05-07
2024-12-31	$602,790	56,600	0.0%	Shares	Sole	2025-02-10
2024-09-30	$718,820	56,600	+18.2%	Shares	Sole	2024-11-07
2022-03-31	$417,209	47,900	+9.1%	Shares	Sole	2022-05-09
2021-12-31	$417,489	43,900	0.0%	Shares	Sole	2022-02-08
2021-09-30	$738,398	43,900	0.0%	Shares	Sole	2021-11-08
2021-06-30	$670,353	43,900	+3.3%	Shares	Sole	2021-08-06
2021-03-31	$827,900	42,500	0.0%	Shares	Sole	2021-05-07
2020-12-31	$765,850	42,500	0.0%	Shares	Sole	2021-02-05
2020-09-30	$819,825	42,500	+6.8%	Shares	Sole	2020-11-09
2020-06-30	$1,039,576	39,800	+15.4%	Shares	Sole	2020-08-05
2020-03-31	$615,480	34,500	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.